Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA
Portfolio Pulse from
Law firm Levi & Korsinsky is preparing a class action lawsuit against Neumora Therapeutics (NMRA) alleging false statements and concealment regarding their Phase Two clinical trials for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims the company manipulated trial inclusion criteria and lacks adequate data to predict Phase Three study results.
March 23, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lawsuit alleges misrepresentations in clinical trial data for Navacaprant, potentially impacting investor confidence and stock performance
The lawsuit directly targets Neumora Therapeutics, alleging serious misrepresentations in clinical trial data. Such legal challenges can significantly damage investor confidence, potentially leading to stock price decline.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100